Organigram Holdings Inc. secured a C$124.6 million strategic investment from BT DE Investments Inc., a subsidiary of British American Tobacco, to strengthen its market position and support growth plans in the cannabis sector.
Information on the Target
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) is a prominent licensed producer of cannabis based in Toronto. The company is known for its commitment to delivering high-quality cannabis products and maintaining strong operational efficiency. Organigram's strategic initiatives and focus on innovation have enabled it to achieve a significant market presence, securing the #2 market position in Canada over recent months.
Recent developments include a C$124.6 million follow-on strategic equity investment from BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco (BAT). This partnership aims to enhance Organigram's growth capabilities, extending its market reach and facilitating further product development.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Canada
The Canadian cannabis industry has experienced remarkable growth and transformation since legalization in 2018. With a focus on cannabis production, processing, and distribution, the sector has seen an influx of
Similar Deals
Clearstone Capital → Brust Beverages
2025
Fondaction, Investissement Québec → Cultures Gen V
2024
Fiducie agricole UPA-Fondaction → Ferme Tournevent
2023
BT DE Investments Inc.
invested in
Organigram Holdings Inc.
in 2023
in a Strategic Partnership deal
Disclosed details
Transaction Size: $92M